Browse > Article

The Anticoagulant Fraction from the Leaves of Diospyros Kaki L. Has an Antithrombotic Activity  

Sa You Seon (Department of Biological Sciences, University of Ulsan)
Kim Soo-Jin (Department of Biological Sciences, University of Ulsan)
Choi Hye-Seon (Department of Biological Sciences, University of Ulsan)
Publication Information
Archives of Pharmacal Research / v.28, no.6, 2005 , pp. 667-674 More about this Journal
Abstract
The leaves of Persimmon (Diospyros kaki L.) has long been used for tea in Korea since it was thought to be effective against hypertension. An anticoagulant fraction was purified through gel filtration G-100, hydrophobic, gel filtration G-150, and FPLC, Phenyl superpose column chromatographies. The purified fraction was homogenous and its Mr was estimated 10,000 Da by gel filtration and SDS-PAGE. The purified fraction was sensitive to treatment of subtilisin B, but not to heat and its activity was not changed after periodate oxidation, indicating that the activity was not due to carbohydrates. It delayed thrombin time (TT), activated partial thromboplastin time (APTT), and prothrombin time (PT) using human plasma. TT was more sensitive than APTT and PT, suggesting that the anticoagulant activity may be caused by a degradation or a defect of fibrin or thrombin. It did not cause the hydrolysis of fibrin after incubation. However, it inhibited thrombin-catalyzed fibrin formation with a competitive inhibition pattern. These results indicate that it may be an antithrombotic agent and that it is bound to fibrinogen binding sites of thrombin.
Keywords
Anticoagulant; Antithrombotic; Leaves of persimmon (Diospyros kaki L.); Thrombin time;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 4  (Related Records In Web of Science)
Times Cited By SCOPUS : 3
연도 인용수 순위
1 Carter, W. J., Myles, T., Gibbs, C. S., Leung, L. L., and Huntington, J. A., Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery. J. Biol. Chem., 279, 26387-26394 (2004)   DOI   ScienceOn
2 Cho, J., Seo, H., Yun, C., Koo, B., Yoshida, S., Koga, T., Dan, T., and Kim, H., In vitro and in vivo stuies of AT-1362, a newly synthesized and orally active inhibitor of thrombin. Thromb. Res., 100, 97-107 (2000)   DOI   ScienceOn
3 Cho, H. R. and Choi, H. S. Effects of anticoagulant from Spirodela polyrhiza in rats. Biosci. Biotechnol. Biochem., 67, 881-883 (2003)   DOI   ScienceOn
4 Herbert, J. M., Herault, J. P., Bernat, A., van Amsterdam, R. G. M., lormeau, J. C., Petitou, M., van Boeckel, C., Hoffmann, P., and Meuleman, D. G., Biochemical and pharmacological properties of Sanorg 34006, a potent and long-acting synthetic pentasaccharide. Blood, 91, 4197-4205 (1998)
5 Jakubowski, J. A. and Maraganore, J. M., Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Blood, 75, 399-406 (1990)
6 Kang, K. T., Jung, B. I., Bae, O. N., Lee, M. Y., Chung, S. M., Lee, J. Y., Lee, S. K., Kim, I. C., and Chung, J. H., Antithrombotic activity of LB30057, a newly synthesized direct thrombin inhibitor. Thromb. Haemost., 89,104-111 (2003)
7 Lettino, M. and Toschi, V., Direct antithrombins: new perspectives in cardiovascular medicine. Curr. Med. Chem. Cardiovasc. Hematol. Agents, 2, 267-275 (2004)   DOI   ScienceOn
8 Liu, F., Craft, R. M., Morris, S. A., and Carroll, R. C., Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker. Expert. Opin. Investig. Drugs, 9, 2673-2687 (2000)   DOI   ScienceOn
9 Noeske-Jungblut, C., Haendler, B., Donner, P., Alagon, A., Possani, L., and Schleu ning, W-D., Triabin, a highly potent exosite inhibitor of thrombin. J. Biol. Chem., 270, 28629-28634 (1995)   DOI
10 Olson, S. T., Bjo, I., Sheffer, R., Craig, P. A., Shore, J. D., and Choay, J., Role of the antithrombin-binding pentasaccharides in heparin acceleration of antithrombin-proteinase reactions. J. Biol. Chem., 267, 12528-12538 (1992)
11 Wall, D., Douglas, S., Ferro, V., Cowden, W., and Parish, C., Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides. Thromb. Res., 103, 325-335 (2001)   DOI   ScienceOn
12 Markwardt, F., Hirudin as alternative anticoagulant-a historical review. Semin. Thromb. Hemost., 28, 405-414 (2002)   DOI   PUBMED   ScienceOn
13 Renda, G., Rocca, B., Crocchiolo, R., Cristofaro, R.D., and Landolfi, R., Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban. Thromb. Haemost., 89, 348-354 (2003)
14 Tsiang, M., Lentz, S. R., Dittman, W. A., Wen, D., Scarpati, E. M., and Sadler, J. E., Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues. Biochemistry, 29, 10602-10612 (1990)   DOI   ScienceOn
15 Choi, H. S. and Sa, Y. S., Fibrinolytic and antithrombotic protease from Spirodela polyrhiza. Biosci. Biotechnol. Biochem., 65, 781-786 (2001)   DOI   ScienceOn
16 Moon, K. S., In Usage of Herbal Medicine (ed. Choi, O. J.), pp 466-468, Ilwolseogak (1991)
17 McClanahan, T. B., Hicks, G. W., Morrison, A. L., Peng, Y. W., Janiczek-Dolphin, N., Mertz, T. E., Sullivan, M. E., Morser, J., Juneau, P. L., and Leadley, R., The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis. Eur. J. Pharmacol., 432,187-194 (2001)   DOI   PUBMED   ScienceOn
18 McGowan, E. B. and Detwiler, T. C., Modified platelet responses to thrombin. Evidence for two types of receptors or coupling mechanisms. J. Biol. Chem., 261, 739-746 (1986)
19 Wong, P. C., Crain, E. J., Watson, C. A., Zaspel, A. M., Wright, M. R., Lam, P. Y., Pinto, D. J., Wexler, R. R., and Knabb, R. M., Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits. J. Pharmacol. Exp. Ther., 303, 993-1000 (2002)   DOI   ScienceOn
20 Stubbs, M. T., Oschkinat, H., Mayr, I., Huber, R., Angliker, H., Stone, S. R., and Bode, W., The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur. J. Biochem., 206, 187-195 (1992)   DOI   ScienceOn
21 Rezaie, A. R., Cooper, S. T., Church, F. C., and Esmon, C. T., Protein C inhibitor is a potent inhibitor of the thrombinthrombomodulin complex. J. Biol. Chem., 270, 25336-25339 (1995)   DOI   ScienceOn
22 Friedrich, T., Kroger, B., Bialojan, S., Lemaire, H. G., Hoffken, H. W., Reuschenbach, P., Otte, M., and Dodt, J., A kazal-type inhibitor with thrombin specificity from Rhodnius prolixus. J. Biol. Chem., 268, 16216-16222 (1993)
23 Yuk, D. Y., Ryu, C. K., Hong, J. T., Chung, K. H., Kang, W. S., Kim, Y., Yoo, H. S., Lee, M. K., Lee, C. K., and Yun, Y. P., Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative. Biochem. Pharmacol., 60, 1001-1008 (2000)   DOI   ScienceOn
24 Hofmann, W. and Bon, C., blood coagulation induced by the venom of Bothrops atrox. 1. Identification, purification, and properties of a prothrombin activator. Biochemistry, 26, 772-776 (1987)   DOI   ScienceOn
25 Strube, K.-H., Kroger, B., Bialojan, S., Otte, M., and Dodt, J., Isolation, sequence analysis, and cloning of haemadin. J. Biol. Chem., 268, 8590-8595 (1993)
26 Muramatsu, R., Sasaki, M., Watanabe, N., Goto, Y., Okayama, T., Nukui, E., Morikawa, T., and Hayashi, H., Antithrombotic effects of NE-6505, a novel anion-binding exosite inhibitor. Thromb. Res., 86, 453-460 (1997)   DOI   ScienceOn
27 Naski, M. C., Fenton II, J. W., Maraganore, J. M., Olson, S. T., and Shafer, J. A., The COOH-terminal domain of hirudin. J. Biol. Chem., 265, 13484-13489 (1990)
28 Holsat, J., Lindblad, B., and Bergqvist, D., Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis-a comparison with low molecular weight heparin. Thromb. Haemost., 71, 214-219 (1994)
29 Okonogi, T., Hattori, Z., Ogiso, A., and Mitsui, S., Detoxification by persimmon tannin of snake venoms and bacterial toxins. Toxicon, 17, 524-527 (1979)   DOI   ScienceOn
30 Richardson, J. L., Kroger, B., Hoeffken, W., Sadler, J. E., Pereira, P., Huber, R., Bode, W., and Fuentes-Prior, P., Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. EMBO J., 19, 5650-5660 (2000)   DOI   PUBMED   ScienceOn
31 Sa, Y. S., Kim, K. A., and Choi, H. S., Purification and characterization of anti-coagulant activity from persimmon stem. J. Kor. Soc. Food Sci. Nutr., 32, 1323-1327 (2003)   과학기술학회마을   DOI